4//SEC Filing
WORLAND STEPHEN T 4
Accession 0001209191-22-038673
CIK 0001828522other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:13 PM ET
Size
5.5 KB
Accession
0001209191-22-038673
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Stock Option (Right to Buy)
2022-06-20+520,674→ 520,674 totalExercise: $1.49Exp: 2032-06-19→ Common Stock (520,674 underlying)
Footnotes (1)
- [F1]The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:13 PM ET
- Size
- 5.5 KB